OpusPoint Partners

OpusPoint Partners, LLC is an investment advisory firm specializing in healthcare and life sciences.

Background
Founded in 2009 by Michael S. Weiss and Lindsay A. Rosenwald, MD, the firm acts as the investment manager for some portfolio private hedge funds in the healthcare and biotechnology sectors.

In October 2010, OpusPoint invested approximately $3 million into National Holdings Corporation and formed a joint venture. As a result, a new investment banking firm, OPN Capital Markets, was established to leverage the resources of both companies.

Among others, OpusPoint Partners participated in the private placement for such companies as Sunesis Pharmaceuticals, Inc. that developed Voreloxin, an anticancer drug used in acute myeloid leukemia.